Hepatitis B control among children in the Eastern Mediterranean Region of the World Health Organization

Vaccine

Volumn 34, Issue 21, 2016, Pages 2403-2409

  Allison, Robert D ^a   Teleb, Nadia ^b   Al Awaidy, Salah ^c   Ashmony, Hossam ^b   Alexander, James P ^a   Patel, Minal K ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c MINISTRY OF HEALTH   (Oman)

Author keywords

Birth dose; EMRO; HBV; Hepatitis B virus; Middle East; North Africa; Vaccination

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN;

BIRTH; CHILD; CHILD HEALTH CARE; CHRONIC HEPATITIS B; CONFLICT; HEALTH CARE POLICY; HUMAN; IMMUNIZATION; INFANCY; INFECTION CONTROL; MOTIVATION; PERINATAL INFECTION; PRIORITY JOURNAL; REVIEW; SEROPREVALENCE; SOUTHERN EUROPE; VACCINATION; WORLD HEALTH ORGANIZATION; COMPLICATION; FEMALE; HEPATITIS B; HEPATITIS B, CHRONIC; INFANT; LIVER CIRRHOSIS; MALE; MORTALITY; PRESCHOOL CHILD; PREVALENCE; PREVENTIVE HEALTH SERVICE; STATISTICS AND NUMERICAL DATA; VIROLOGY;

CHILD; CHILD, PRESCHOOL; FEMALE; HEPATITIS B; HEPATITIS B VACCINES; HEPATITIS B, CHRONIC; HUMANS; IMMUNIZATION PROGRAMS; INFANT; LIVER CIRRHOSIS; MALE; MEDITERRANEAN REGION; PREVALENCE; VACCINATION; WORLD HEALTH ORGANIZATION;

EID: 84962421696     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2016.03.063     Document Type: Review

References (29)

1. World Health Organization Hepatitis B vaccines. Wkly Epidemiol Rec 2009, 84(October (40)):405-419.
2. Lozano R., Naghavi M., Foreman K., Lim S., Shibuya K., Aboyans V., et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380(December (9859)):2095-2128.
3. Perz J.F., Armstrong G.L., Farrington L.A., Hutin Y.J., Bell B.P. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006, 45(October (4)):529-538.
4. World Health Organization Technical Paper. The growing threats of hepatitis B and C in the Eastern Mediterranean Region: a call for action 2009, Available at http://www.emro.who.int/surveillance-forecasting-response/strategy/regional-committee-resolutions.html [accessed 01.07.15].
5. Goldstein S.T., Zhou F., Hadler S.C., Bell B.P., Mast E.E., Margolis H.S. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 2005, 34(December (6)):1329-1339.
6. Schweitzer A., Horn J., Mikolajczyk R.T., Krause G., Ott J.J. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet 2015, 386(October (10003)):1546-1555.
7. World Health Organization WHO/UNICEF joint reporting form on immunization: WHO vaccine preventable diseases monitoring system 2015, Available at http://apps.who.int/immunization_monitoring/globalsummary [accessed 26.07.15].
8. Burton A., Monasch R., Lautenbach B., Gacic-Dobo M., Neill M., Karimov R., et al. WHO and UNICEF estimates of national infant immunization coverage: methodology and processes. Bull World Health Organ 2009, 87(July (7)):535-541.
9. Mast E.E., Margolis H.S., Fiore A.E., Brink E.W., Goldstein S.T., Wang S.A., et al. Advisory Committee on Immunization Practices (ACIP). A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep 2005, 54(December (RR-16)):1-31.
10. World Health Organization Department of Immunization, Vaccines Biologicals Practices to improve coverage of the hepatitis B birth dose vaccine 2012, World Health Organization, Geneva, Report No.: WHO/IVB/11.08.
11. World Health Organization Department of Immunization, Vaccines Biologicals Documenting the impact of hepatitis B immunization: best practices for conducting a serosurvey 2011, World Health Organization, Geneva, Report No.: WHO/IVB/11.08.
12. Hennessey K., Mendoza-Aldana J., Bayutas B., Lorenzo-Mariano K.M., Diorditsa S. Hepatitis B control in the World Health Organization's Western Pacific Region: targets, strategies, status. Vaccine 2013, 31(December (Suppl. 9)):J85-J92.
13. Teleb N., Lebo E., Ahmed H., Hossam A.R., El Sayed el T., Dabbagh A., et al. Progress toward measles elimination - Eastern Mediterranean Region, 2008-2012. MMWR Morb Mortal Wkly Rep 2014, 63(June (23)):511-515.
14. Smith J., Leke R., Adams A., Tangermann R.H. Certification of polio eradication: process and lessons learned. Bull World Health Organ 2004, 82(January (1)):24-30.
15. Al Awaidy S.T., Bawikar S.P., Al Busaidy S.S., Al Mahrouqi S., Al Baqlani S., Al Obaidani I., et al. Progress toward elimination of hepatitis B virus transmission in Oman: impact of hepatitis B vaccination. Am J Trop Med Hyg 2013, 89(October (4)):811-815.
16. Widaa N.M. Sero-epidemiology of hepatitis B among children <10 years of age in Khartoum State 2004-2005 2006, [Thesis], University of Khartoum, Kartoum: n.p. Print.
17. Mao B., Patel M.K., Hennessey K., Duncan R.J., Wannemuehler K., Soeung S.C. Prevalence of chronic hepatitis B virus infection after implementation of a hepatitis B vaccination program among children in three provinces in Cambodia. Vaccine 2013, 31(September (40)):4459-4464.
18. Wang L., Li J., Chen H., Li F., Armstrong G.L., Nelson C., et al. B vaccination of newborn infants in rural China: evaluation of a village-based, out-of-cold-chain delivery strategy. Bull World Health Organ 2007, 85(September (9)):688-694.
19. Otto B.F., Suarnawa I.M., Stewart T., Nelson C., Ruff T.A., Widjaya A., et al. At-birth immunisation against hepatitis B using a novel pre-filled immunization device stored outside the cold chain. Vaccine 1999, 18(October (5-6)):498-502.
20. Hipgrave D.B., Tran T.N., Huong V.M., Dat D.T., Nga N.T., Long H.T., et al. Immunogenicity of a locally produced hepatitis B vaccine with the birth dose stored outside the cold chain in rural Vietnam. Am J Trop Med Hyg 2006, 74(February (2)):255-260.
21. Glenton C., Khanna R., Morgan C., Nilsen E.S. The effects, safety and acceptability of compact, pre-filled, auto disable injection devices when delivered by lay health workers. Trop Med Int Health 2013, 18(August (8)):1002-1016.
22. Sutanto A., Suarnawa I.M., Nelson C.M., Stewart T., Soewarso T.I. Home delivery of heat-stable vaccines in Indonesia: outreach immunization with a prefilled, single-use injection device. Bull World Health Organ 1999, 77(2):119-126.
23. Joshi N., Kumar A., Raghu M.B., Bhave S., Arulprakash R., Bhusari P., et al. Immunogenicity and safety of hepatitis B vaccine (Shanvac-B) using a novel pre-filled single use injection device Uniject in Indian subjects. Indian J Med Sci 2004, 58(November (11)):472-477.
24. Levin C.E., Nelson C.M., Widjaya A., Moniaga V., Anwar C. The costs of home delivery of a birth dose of hepatitis B vaccine in a prefilled syringe in Indonesia. Bull World Health Organ 2005, 83(June (6)):456-461.
25. Obradovic Z., Balta S., Obradovic A., Mesic S. The impact of war on vaccine preventable diseases. Mater Sociomed 2014, 26(December (6)):382-384.
26. Cetorelli V. The impact of the Iraq War on neonatal polio immunization coverage: a quasi-experimental study. J Epidemiol Community Health 2015, 69(March (3)):226-231.
27. Mashal T., Nakamura K., Kizuki M., Seino K., Takano T. Impact of conflict on infant immunisation coverage in Afghanistan: a countrywide study 2000-2003. Int J Health Geogr 2007, 6(June):23.
28. United Nations Office for the Coordination of Humanitarian Affairs. Syria crisis: regional overview. Available at [accessed 05.07.15]. http://www.unocha.org/syrian-arab-republic/syria-country-profile/about-crisis.
29. Centers for Disease Control and Prevention (CDC) Vaccination services in postwar Iraq May 2003. MMWR Morb Mortal Wkly Rep 2003, 52(August (31)):734-735.